1 |
Mahler, Jackson C, Ijacu H. The burden of psoriasis and barriers to satisfactory care: results from a Canadian patient survery. J Cutan Med Surg 2009; 13: 283-93.
DOI
URL
|
2 |
Akiyama K, Chen C, Wang DD, et al. Mesenchymalstem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem cell 2012; 10: 544-55.
DOI
URL
|
3 |
Li Q, Ma Y, Li L, et al. Flagellin influences the expression of a variety of important cytokines and chemokines without affecting the immune status of umbilical cord mesenchymal stem cells. Mol Med Rep 2015; 12: 6955-61.
DOI
URL
|
4 |
Cao K, Zhang T. Progress in immunoregulatory plasticity of mesenchymal stem cells. Medical review 2018; 24 : 34-9.
|
5 |
Zhou DM, Wang P, Chen WW, et al. An analysis of the theoretical evolution from treating psoriasis from blood to Qi, blood and body fluid. Beijing Zhong Yi Yao 2019; 38: 755-9.
|
6 |
Zhang K, Liu R, Yin G, et al. Differential cytokine secretion of cultured bone marrow stromal cells from patiens with psoriasis and healthy volunteers. Eur J Dermatol 2010; 20, 49-53.
DOI
URL
|
7 |
Peng SN, Tao YX, Hong T, et al. Astragaloside Ⅳ regulating differentiation of splenic lymphocyte of IgA nephropathy rats via mTORC 1 pathway. Zhong Guo Mian Yi Xue Za Zhi 2021; 37: 421-5.
|
8 |
Zhou X, Liu Rf, Zhang K, et al. Detection of interleukin and vascular endothelial growth factor secreted by psoriatic bone marrow mesenchymal stem cells. Lin Chuang Pi Fu Za Zhi 2014; 5: 22-8.
|
9 |
Hou R, Liu R, Niu X, et al. Biological characteristics and gene expression pattern of bone marrow mesenchymal stem cells in patients with psoriasis. Exp Dermatol 2014; 23: 521-3.
DOI
URL
|
10 |
Munir H, Ward LSC, Sheriff L, et al. Adipogenic differentiation of MSC alters their immunomodulatory properties in a tissue-specific manner. Stem Cells 2017; 35: 1636-46.
DOI
URL
|
11 |
Jia YR, Jia XL, Hou RX, et al. Gene expression and biological characteristics of bone marrow mesenchymal stem cells in patients with psoriasis. Shanxi Yi Yao Za Zhi 2016; 45: 20-3.
|
12 |
Kode JA, Mukherjee S, Joglekar MV, et al. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009; 11: 377-91.
DOI
URL
|
13 |
English K. Mechanisms of mesenchymal stromal celli-mmunomodulation. Immunol Cell Biol 2013; 91: 19-26.
DOI
PMID
|
14 |
Qu X, Liu X, Cheng K, et al. Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10 secretion. Exp Hematol 2012; 40: 761-70.
DOI
URL
|
15 |
Huang QL, Wei XF. Plasticity of immune regulation of mesenchymal stem cells. Zhong Guo Ke Xue: Sheng Ming Ke Xue 2016; 46: 79-808.
|
16 |
Waterman RS, Tomchuck SL, Henkle SL, et al. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS One 2010; 5: e10088.
|
17 |
Zhong QC. Discussing the pathogenesis and treatment of systemic lupus erythematosus from the connection between Traditional Chinese Medicine and modern immunology. Xin Zhong Yi 2004; 36: 3-6.
|
18 |
Song P, Wang XX, Yang MY, et al. Observation of 120 cases of plaque psoriasis treated by opening Xuanfu and dredging collaterals and detoxifying methods. Zhong Yi Za Zhi 2013; 54: 1476-1479.
|
19 |
Yin XP. Zhou RJ, Zhuang C, et al. Isolating culture of adipose mesenchymal stem cells in psoriasis vulgaris patients and differentiation into immune regulation function. Ji Chu Yi Xue Yu Lin Chuang 2017; 37: 975-80.
|